Shanghai Pharmaceuticals Holding Co., Ltd
601607
Classifica tra le azioni
#2386
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Prezzo delle azioni
$2.43
Capitalizzazione di mercato
$8.09B
Variazione (1 giorno)
-1.16%
Variazione (1 anno)
-5.94%
Paese
CN
Scambia Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Categoria
Healthcare
Utile per Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Shanghai Pharmaceuticals Holding Co., Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Shanghai Pharmaceuticals Holding Co., Ltd dal 2001 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2025 | $1.40B | 27.74% |
| 2024 | $1.10B | 10.26% |
| 2023 | $996.57M | -21.96% |
| 2022 | $1.28B | -0.34% |
| 2021 | $1.28B | 16.65% |
| 2020 | $1.10B | 22.13% |
| 2019 | $899.35M | 15.77% |
| 2018 | $776.81M | -2.90% |
| 2017 | $799.98M | 19.73% |
| 2016 | $668.16M | 4.00% |
| 2015 | $642.44M | 4.72% |
| 2014 | $613.46M | 15.36% |
| 2013 | $531.78M | 7.40% |
| 2012 | $495.16M | 2.85% |
| 2011 | $481.45M | 46.27% |
| 2010 | $329.15M | 533.08% |
| 2009 | $51.99M | 90.01% |
| 2008 | $27.36M | 36.33% |
| 2007 | $20.07M | 54.40% |
| 2006 | $13.00M | 6.28% |
| 2005 | $12.23M | -46.95% |
| 2004 | $23.06M | -26.01% |
| 2003 | $31.16M | 20.81% |
| 2002 | $25.79M | 5.48% |
| 2001 | $24.45M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $6.46B | - |
US
|
|
| - | - |
US
|
|
| $2.17B | - |
US
|
|
| - | - |
US
|
|
| $708.86M | - |
AU
|
